DROR · Dror Ortho-Design, Inc. · Insider Trading

$0.01 At close · Oct 16

Market Cap

$8.30M

977.00M

Volume · Oct 16 1010 Avg daily vol (3M) 129.18K

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.

Query insider transactions through the insider trading API or MCP →

Date	Insider	Role	Type	Security	Shares	Price	Value	After
2024-06-17	Hurvitz Chaim	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The stock options vested fully upon the date of grant.	Stock Option (Right to Buy)	21,122,239	$0.00	$78,152	21,122,239
2024-06-17	Englander Yehuda	Director	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The stock options vested two-thirds upon the date of grant, and the remainder vests on June 1, 2025, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate.	Stock Option (Right to Buy)	9,597,675	$0.00	$35,511	9,597,675
2024-06-17	Shvets Moshe	Director, Chief Technology Officer	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date.	Stock Option (Right to Buy)	57,578,694	$0.00	$213,041	57,578,694
2024-06-17	Haddad Eliyahu	Director, Chief Executive Officer	Award↑ Filing footnotes — Stock Option (Right to Buy) (Direct) The stock options vested two-thirds upon the date of grant, and the remainder vests on December 6, 2024, subject to earlier vesting upon the achievement of patient use objectives, provided the Reporting Person is employed by or providing services to the Issuer or an affiliate on the applicable vesting date.	Stock Option (Right to Buy)	95,965,715	$0.00	$355,073	95,965,715
2023-09-13	Haddad Eliyahu	Director, Chief Executive Officer	Award↑ Filing footnotes — Common Warrants (Direct) Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). Warrants expire on the fifth anniversary of the Initial Exercise Date.	Common Warrants	45,454,545	—	—	45,454,545
2023-09-13	Haddad Eliyahu	Director, Chief Executive Officer	Award↑ Filing footnotes — Series A Convertible Preferred Stock (Direct) Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. The Preferred Stock is perpetual and therefore has no expiration date.	Series A Convertible Preferred Stock	454,545	$1.10	$500,000	454,545
2023-08-14	Ravad Chaim	Director	Award↑ Filing footnotes — Common Warrants (Direct) Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 62,071 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange"). Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). Warrants expire on the fifth anniversary of the Initial Exercise Date.	Common Warrants	228,251,826	—	—	228,251,826
2023-08-14	Hurvitz Chaim	Director	Award↑ Filing footnotes — Common Warrants (Indirect) Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 7,109 ordinary shares of Private Dror held by Shirat Hachaim, representing all warrants to purchase ordinary shares of Private Dror beneficially owned by the reporting person, were cancelled, and the Company issued to Shirat Hachaim warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share. Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). Warrants expire on the fifth anniversary of the Initial Exercise Date. The securities are held by Shirat Hachaim, an entity of which the reporting person is the sole owner and over whose shares the reporting person has sole voting and dispositive power .	Common Warrants (I)	42,417,309	—	—	42,417,309
2023-08-14	Ravad Chaim	Director	Award↑ Filing footnotes — Series A Convertible Preferred Stock (Direct) Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 58,493 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange"). Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. The Preferred Stock is perpetual and therefore has no expiration date.	Series A Convertible Preferred Stock	2,150,945	—	—	2,150,945
2023-08-14	Shvets Moshe	Director, Chief Technology Officer	Award↑ Filing footnotes — Series A Convertible Preferred Stock (Direct) Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, the reporting person transferred 18,808 ordinary shares of Private Dror, representing all ordinary shares of Private Dror held by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange"). Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. The Preferred Stock is perpetual and therefore has no expiration date.	Series A Convertible Preferred Stock	691,620	—	—	691,620
2023-08-14	Hurvitz Chaim	Director	Award↑ Filing footnotes — Series A Convertible Preferred Stock (Indirect) Pursuant to a Share Exchange Agreement, dated July 5, 2023 (as amended, the "Share Exchange Agreement"), by and among the Company, Dror Ortho-Design Ltd. ("Private Dror"), and the shareholders of Private Dror, Shirat Hachaim Ltd ("Shirat Hachaim") transferred 16,103 ordinary shares of Private Dror, representing all ordinary shares of Private Dror beneficially owned by the reporting person, to the Company in exchange for shares of Preferred Stock (the "Share Exchange"). Shares of Series A Convertible Preferred Stock, par value $0.0001 per share and with a stated value of $1.10 per share (the "Preferred Stock") of Dror Ortho-Design, Inc. (formerly Novint Technologies, Inc.) (the "Company") shall be convertible, at any time and from time to time at the option of the Holder thereof, into shares of the company's common stock, par value $0.0001 per share (the "Common Stock") from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the Preferred Stock. The Preferred Stock is perpetual and therefore has no expiration date. The securities are held by Shirat Hachaim, an entity of which the reporting person is the sole owner and over whose shares the reporting person has sole voting and dispositive power .	Series A Convertible Preferred Stock (I)	592,150	—	—	592,150
2023-08-14	Shvets Moshe	Director, Chief Technology Officer	Award↑ Filing footnotes — Common Warrants (Direct) Pursuant to a Warrant Exchange Agreement, dated August 14, 2023, between the Company and the reporting person, simultaneously with the Share Exchange, warrants to purchase 7,109 ordinary shares of Private Dror, representing all warrants to purchase ordinary shares of Private Dror held by the reporting person, were cancelled, and the Company issued to the reporting person warrants to purchase shares of the Company's Common Stock with an exercise price of $0.033 per share (the "Warrant Exchange"). Warrants will be exercisable from and after the date the Company has reserved shares of Common Stock on behalf of the holders of the warrants (the "Initial Exercise Date"). Warrants expire on the fifth anniversary of the Initial Exercise Date.	Common Warrants	26,141,712	—	—	26,141,712

Legend Buy — open-market purchase Sell — open-market sale ↑ Shares acquired ↓ Shares disposed (gift, conversion, tax…)

Showing 1–12 of 12 transactions

Key facts CIK 1282980 Visit website Investor relations